journal article·2025-09

A hypoxia-activated nano prodrug for enhanced chemotherapy and photodynamic synergistic therapy with minimized chemotherapy side effect

Peng-Wei Chen, Yu-Meng Zhang, Lin-Song Li, Bang-Bang Liu, Liping Chen, Xiaojing Yang, Mei-Xia Zhao

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. In vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer10.1016/j.biomaterials.2020.120430 ↗
2. Light-triggered nanozymes remodel the tumor hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumor immunity10.1021/acsnano.4c00844 ↗
3. A “precision medicine” nanoplatform for synergistic photothermal therapy and chemotherapy in hepatocellular carcinoma
4. Engineering supramolecular nanomedicine for targeted near infrared-triggered mitochondrial dysfunction to potentiate cisplatin for efficient chemophototherapy10.1021/acsnano.1c09555 ↗
5. A CuS/Ag/Pt@ICG/DOX nanoplatform with cascaded nanozyme catalysis for tumor microenvironment remodeling and synergistic photodynamic/photothermal/chemodynamic therapy10.1016/j.colsurfb.2025.114743 ↗
6. pH-responsive AIE nanogels for synergistic chemo-photodynamic cancer therapy with imaging guidance10.1007/s11426-024-2379-x ↗
7. Nuclear-targeted smart nanoplatforms featuring double-shell hollow mesoporous copper sulfide coated with manganese dioxide synergistically potentiate chemotherapy and immunotherapy in hepatocellular carcinoma cells10.1016/j.jcis.2024.11.003 ↗
8. “transforming enemy into friend” strategy-based stimuli responsive dual-drug liposomes for synergistic chemo-photodynamic therapy10.1016/j.cej.2024.150526 ↗
9. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy10.1016/j.actbio.2024.02.048 ↗
10. Tumor-activated photosensitization and size transformation of nanodrugs
11. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
12. A glutathione activatable pro-drug-photosensitizer for combined chemotherapy and photodynamic therapy10.1016/j.cclet.2022.03.040 ↗
13. Hypoxia exacerbation-triggered doxorubicin prodrug activation for sequential photodynamic/chemotherapy10.1021/acsmaterialslett.4c00798 ↗
14. Hypoxia-activated PEGylated paclitaxel prodrug nanoparticles for potentiated chemotherapy10.1021/acsnano.2c05341 ↗
15. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments10.1186/s12943-020-01288-1 ↗
16. A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer10.1038/s41467-024-53906-x ↗
17. Hypoxia-adaptive penetration enhanced nanomedicine regulating cell–internalization ability enabling the uniform distribution within tumors
18. Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy10.1038/s41467-025-55905-y ↗
19. Photodynamic therapy-accelerated hypoxia-responsive prodrug release for synergistic photo-chemotherapy of melanoma cancer based on noncovalent interactions10.1021/acsmaterialslett.4c02496 ↗
20. A photo-accelerated nanoplatform for image-guided synergistic chemo-photodynamic therapy
21. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
22. A hypoxia-activated BODIPY-azo anticancer prodrug for bimodal chemo-photodynamic therapy10.1021/acs.jmedchem.4c02231 ↗
23. A dendritic drug–drug conjugate self-assembled hypoxia-responsive supramolecular nanoparticle for combination therapy10.1039/D4TB02400A ↗
24. HClO-activated fluorescence and photosensitization from an AIE nanoprobe for image-guided bacterial ablation in phagocytes10.1002/adma.202005222 ↗
25. Tumor-activated and metal–organic framework assisted self-assembly of organic photosensitizers10.1021/acsnano.0c04518 ↗
26. Universal scaffold for an activatable photosensitizer with completely inhibited photosensitivity10.1002/anie.201907510 ↗
27. Synchronized activating therapeutic nano-agent: enhancement and tracing for hypoxia-induced chemotherapy10.1016/j.biomaterials.2023.122365 ↗
28. Designing squaraine dyes with bright deep-red aggregation-induced emission for specific and ratiometric fluorescent detection of hypochlorite10.1002/adfm.202105452 ↗
29. Rationally designed heptamethine cyanine photosensitizers that amplify tumor-specific endoplasmic reticulum stress and boost antitumor immunity
30. H-aggregates of prodrug-hemicyanine conjugate for enhanced photothermal therapy and sequential hypoxia-activated chemotherapy10.1021/acsmaterialslett.2c00015 ↗
31. Hypoxia-responsive near infrared thioxanthene-hemicyanine nanoparticle for multimodal imaging-guided photothermal/photodynamic therapy10.1016/j.dyepig.2022.110583 ↗
32. NIR-II AIE liposomes for boosting type-I photodynamic and mild-temperature photothermal therapy in breast cancer treatment10.1002/adma.202411133 ↗
33. Harnessing donor cyclization strategy: converting type II to type I photosensitizers and enhancing AIE performance for NIR-II FL/MR imaging-guided photodynamic therapy under hypoxia condition
34. Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy10.1016/j.actbio.2024.04.014 ↗
35. An AIE photosensitizer with simultaneous type I and type II ROS generation: efficient bacterial elimination and hypoxic tumor ablation
36. Highly efficient multifunctional organic photosensitizer with aggregation-induced emission for in vivo bioimaging and photodynamic therapy10.1021/acsami.1c17476 ↗
37. An NIR-II two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma
38. The midas touch by iridium: a second near-infrared aggregation-induced emission-active metallo-agent for exceptional phototheranostics of breast cancer10.1021/jacs.4c15150 ↗
39. Advanced photosensitizer activation strategies for smarter photodynamic therapy beacons10.1002/anie.201805246 ↗
40. Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapy10.1016/j.biomaterials.2021.120945 ↗
41. Leveraging tumor microenvironment to boost synergistic photodynamic therapy, ferroptosis anti-tumor efficiency based on a functional iridium(III) complex10.1002/advs.202413879 ↗
42. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
43. Bioorthogonal activation and mitochondrial targeting of a near-infrared-emitting iridium(III) nitrone complex via cyclooctynylated phosphonium cations for enhanced cellular imaging and photodynamic therapy10.1039/D5QI01139F ↗
44. Mitochondrial electron flow dynamics imaging for assessing mitochondrial quality and drug screening
45. Photoactivated self-assembled nanomicelles integrating mitophagy inhibition to enhance pyroptosis for cancer immunotherapy
46. A small-molecule drug for the self-checking of mitophagy
47. Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment10.1002/adma.201803001 ↗
48. Polyphotosensitizer-based nanoparticles with michael addition acceptors inhibiting GST activity and cisplatin deactivation for enhanced chemotherapy and photodynamic immunotherapy
49. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
50. A PTT-induced feed-back carbon nanosystem for enhanced breast cancer therapy by extracellular matrix remodeling10.1021/acs.nanolett.4c05625 ↗
51. β-ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression
52. Chimeric peptide-engineered polyprodrug enhances cytotoxic T cell response by inducing immunogenic cell death and upregulating major histocompatibility complex class I10.1021/acsnano.4c12197 ↗